IL-17A is the key effector cytokine produced by pro-inflammatory T helper 17 (Th17) cells, CD8+ and γδ T cells and by other cells in the CNS, such as astrocytes and oligodendrocytes in active MS lesions [89]. Here, IL17A is linked to myeloid sarcoma.